Skye Bioscience, Inc. SKYE
1.14 USD -0.08 (-6.56%)
At closeNov 4, 2026, 4:00 PM EST
1.14 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
1.11 Day range 1.30
1.11 52-week range 12.80
- YTD
- -81.00%
- 1 year
- -89.96%
Held by funds
2 US ETFs and mutual funds hold SKYE · largest positions
Ownership
Held by insiders 1.32%
Held by institutions 86.03%
Float held by institutions 87.18%
Institutions 100
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| 5AM Venture Management, LLC | 35.32% | 9,913,168 | 26.07M | Sep 29, 2024 |
| Versant Venture Management, LLC | 7.15% | 2,007,704 | 5.28M | Sep 29, 2024 |
| Sphera Funds Management Ltd. | 5.57% | 1,563,522 | 4.11M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 5.11% | 1,434,634 | 3.77M | Sep 29, 2024 |
| Altium Capital Management, LP | 4.69% | 1,315,146 | 3.46M | Sep 29, 2024 |
| Blackrock Inc. | 4.25% | 1,193,515 | 3.14M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.70% | 477,100 | 1.25M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.59% | 446,814 | 1.18M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.89% | 249,751 | 656.85K | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.63% | 176,099 | 463.14K | Aug 30, 2024 |
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 0.57% | 160,000 | 420.80K | Oct 30, 2024 |
| iShares Russell 2000 Value ETF | 0.49% | 136,819 | 359.83K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 5AM PARTNERS VII, LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 12, 2024 | 0 |
| ARSENAULT KAITLYN MELANIE | Chief Financial Officer | Sale | Nov 17, 2024 | 166,342 |
| DHILLON PUNIT S | Chief Executive Officer | Sale | Nov 17, 2024 | 339,166 |
| DIEP TUAN TU | Officer | Sale | Nov 17, 2024 | 82,259 |
| EMERALD HEALTH SCIENCES, INC. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 21, 2023 | 169,408,000 |
| GRAYSON PAUL A | Director | Sale | Nov 17, 2024 | 259,701 |